MISSISSAUGA, ON, Jan. 18, 2019 /CNW/ - Aralez Pharmaceuticals Inc. (the "Company") announced today it has filed a current report on Form 8-K regarding certain organizational changes in connection with the winding down of its operations in connection with its bankruptcy proceedings.
A copy of the current report on Form 8-K filed in connection with such organizational changes with respect to the winding down of the Company's operation is incorporated by reference herein and has been filed on EDGAR at www.sec.gov and on SEDAR at www.sedar.com.
Information about the Company and the court-supervised proceedings are available at a website administered by the Company's claims agent, Primeclerk, at https://cases.primeclerk.com/Aralez. Information is also available at a website maintained by Richter Advisory Group Inc., the Company's court-appointed monitor in Canada, in accordance with the Canadian court proceedings, at http://insolvency.richter.ca/A/Aralez-Pharmaceuticals.
SOURCE Aralez Pharmaceuticals Inc.
For further information: please call 1-877-676-4390 or e-mail at email@example.com.